Trans-fatty acids (TFAs), or trans-fats, are an important public health problem that has many negative consequences for human health and requires multi-stakeholder health policy interventions for its solution. TÜSEB Turkish Institute for Health Policies, the Ministry of Health of Turkey and the WHO Coun...
High-quality research is important for improving population health and well-being and for achieving
the health-related Sustainable Development Goals. The challenges facing individuals, organizations and
countries in securing research funding and building research capacity, and then using these resources
...
The WHO European Region has the highest levels of alcohol consumption per capita in the world, yet alcohol
labelling, a WHO-recommended practice that provides consumer information on the ingredients, nutritional
values and harms of alcohol, is not mandatory. This report synthesizes evidence on alcohol la...
Men are less likely than women to seek help for mental health issues and are much more likely to commit
suicide. This scoping review examined recent evidence published in English and Russian on the role of socially
constructed masculinity norms in men’s help-seeking behaviour for mental health issues. ...
By September 2019, some 80 million poor households will have been connected to LPG since 2015 through the national programme, Pradhan Mantri Ujjwala Yojana (Ujjwala). This is in addition to “normal” growth in LPG connections amounting to approximately 40 million households. By any account, this is a ...
Affordability is a key barrier to access to medicines. Generic medicines policies can address this barrier and promote access. Successful uptake of generic medicines depends, in part, on ensuring that these products are interchangeable with reference products. Typically, bioequivalence certification is e...
Chile implemented a generic substitution policy in 2014 to improve access to medicines. This study aims to measure if the generic substitution policy had an effect on the sales volume and prices of referent and the branded generic products with demonstrated bioequivalence (BEQ) in the private pharmaceuti...
Ontario has both a health system and a research system that are increasingly aiming to support rapid learning and improvement. Yet, Ontario's health system still faces complex challenges, such as reducing emergency-room wait times, ending hallway medicine, improving support for people with mental health ...
This report (Report 1) is a policy summary which underpins the key theme of
the conference – financial sustainability in health systems. The report touches
on the myriad elements involved in discussions on financial sustainability, and
emphasizes the need for a clarification of the key concepts as a pr...
The Health Evidence Network (HEN) is an information service for public health decision-makers in the
WHO European Region, in action since 2003 and initiated and coordinated by the WHO Regional Office for
Europe under the umbrella of the WHO European Health Information Initiative (a multipartner network
c...
